Passa al contenuto
Merck
Tutte le immagini(1)

Key Documents

Altri documenti

1003009

USP

Acetaminofene

United States Pharmacopeia (USP) Reference Standard

Sinonimo/i:

4′-idrossiacetanilide, 4-acetamidofenolo, N-(4-idrossifenil)acetammide, N-acetil-4-amminofenolo, APAP, Paracetamolo

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula condensata:
CH3CONHC6H4OH
Numero CAS:
103-90-2
Peso molecolare:
151.16
Beilstein:
2208089
Numero MDL:
MFCD00002328
Codice UNSPSC:
41116107
ID PubChem:
329748124
NACRES:
NA.24

Grado

pharmaceutical primary standard

Famiglia di API

acetaminophen, paracetamol

Produttore/marchio commerciale

USP

Punto di fusione

168-172 °C (lit.)

applicazioni

pharmaceutical (small molecule)

Formato

neat

Stringa SMILE

CC(=O)Nc1ccc(O)cc1

InChI

1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)
RZVAJINKPMORJF-UHFFFAOYSA-N

Informazioni sul gene

human ... FAAH(2166) , PTGS1(5742) , PTGS2(5743) , TRPV1(7442)

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Categorie correlate

Descrizione generale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Applicazioni

Acetaminophen USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Also, for use with USP monographs such as:
  • Acetaminophen Tablets
  • Acetaminophen Capsules
  • Acetaminophen Suppositories
  • Acetaminophen Oral Suspension
  • Acetaminophen Oral Solution
  • Acetaminophen and Caffeine Tablets
  • Acetaminophen Extended-Release Tablets

Analgesico.

Risultati analitici

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Altre note

Sales restrictions may apply.

Prodotti correlati

N° Catalogo
Descrizione
Determinazione del prezzo

PHR1148

4-Aminophenol (Acetaminophen Related Compound K) (Paracetamol Impurity K), Pharmaceutical Secondary Standard; Certified Reference Material

PHR1149

4′-cloroacetanilide, Pharmaceutical Secondary Standard; Certified Reference Material

1021204

4-Aminophenol, United States Pharmacopeia (USP) Reference Standard

P0300000

Acetaminofene, European Pharmacopoeia (EP) Reference Standard

PHR1531

2-acetamidofenolo, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1612

Acetaminophen Related Compound A, Pharmaceutical Secondary Standard; Certified Reference Material

1003100

Composto J correlato ad acetaminofene, United States Pharmacopeia (USP) Reference Standard

1003031

Composto C correlato ad acetaminofene, United States Pharmacopeia (USP) Reference Standard

Y0001781

Acetaminofene, European Pharmacopoeia (EP) Reference Standard

PHR1745

4-Aminophenol hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

BP371

Acetaminofene, British Pharmacopoeia (BP) Reference Standard

Y0001945

4′-cloroacetanilide, European Pharmacopoeia (EP) Reference Standard

Y0001955

Paracetamol impurity K, European Pharmacopoeia (EP) Reference Standard

Pittogrammi

Exclamation mark
GHS07

Avvertenze

Warning

Indicazioni di pericolo

H302

Classi di pericolo

Acute Tox. 4 Oral

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 1

Punto d’infiammabilità (°F)

364.3 °F - Pensky-Martens closed cup

Punto d’infiammabilità (°C)

184.6 °C - Pensky-Martens closed cup

Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 6

1 of 6

Composto J correlato ad acetaminofene United States Pharmacopeia (USP) Reference Standard

USP

1003100

Composto J correlato ad acetaminofene

Acetaminophen solution 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

A-064

Acetaminophen solution

Acetaminofene European Pharmacopoeia (EP) Reference Standard

Y0001781

Acetaminofene

Aspirin United States Pharmacopeia (USP) Reference Standard

USP

1044006

Aspirin

4-Aminophenol (Acetaminophen Related Compound K) (Paracetamol Impurity K) Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1148

4-Aminophenol (Acetaminophen Related Compound K) (Paracetamol Impurity K)

Chlorpheniramine maleate United States Pharmacopeia (USP) Reference Standard

USP

1123000

Chlorpheniramine maleate

Acetaminophen
USP43-NF38: United States Pharmacopeia and National Formulary
United States Pharmacopeia, 39(6), 38-38 (2020)
Acetaminophen tablets
USP43-NF38: United States Pharmacopeia and National Formulary
United States Pharmacopeia, 43(3), 45-45 (2021)
Mitchell R McGill et al.
Pharmaceutical research, 30(9), 2174-2187 (2013-03-07)
Acetaminophen (APAP) is one of the most widely used drugs. Though safe at therapeutic doses, overdose causes mitochondrial dysfunction and centrilobular necrosis in the liver. The first studies of APAP metabolism and activation were published more than 40 years ago.
Garry G Graham et al.
Inflammopharmacology, 21(3), 201-232 (2013-05-31)
Paracetamol is used worldwide for its analgesic and antipyretic actions. It has a spectrum of action similar to that of NSAIDs and resembles particularly the COX-2 selective inhibitors. Paracetamol is, on average, a weaker analgesic than NSAIDs or COX-2 selective
Karel Allegaert et al.
Archives of disease in childhood, 98(6), 462-466 (2013-04-23)
There remains a need for alternative medical treatments for patent ductus arteriosus (PDA) closure in extreme preterm neonates because of therapeutic failure and adverse effects associated with non-selective cyclo-oxygenase inhibitors. Reports of an association between paracetamol exposure and PDA closure
Visualizza tutti i documenti correlati

Articoli

HPLC Analysis of Pain Relievers on Ascentis® Express C18

Separation of Acetaminophen, meets USP testing specifications, 98.0-102.0%, powder; Caffeine, meets USP testing specifications, anhydrous; Benzoic acid, meets USP testing specifications; Aspirin, meets USP testing specifications

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.